HomeCompareHKMPF vs ADC

HKMPF vs ADC: Dividend Comparison 2026

HKMPF yields 4.85% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HKMPF wins by $302.38M in total portfolio value
10 years
HKMPF
HKMPF
● Live price
4.85%
Share price
$17.30
Annual div
$0.84
5Y div CAGR
85.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$302.56M
Annual income
$279,218,818.50
Full HKMPF calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — HKMPF vs ADC

📍 HKMPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHKMPFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HKMPF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HKMPF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HKMPF
Annual income on $10K today (after 15% tax)
$412.45/yr
After 10yr DRIP, annual income (after tax)
$237,335,995.73/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, HKMPF beats the other by $237,268,295.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HKMPF + ADC for your $10,000?

HKMPF: 50%ADC: 50%
100% ADC50/50100% HKMPF
Portfolio after 10yr
$151.37M
Annual income
$139,649,232.87/yr
Blended yield
92.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

HKMPF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
3.5
Piotroski
7/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HKMPF buys
0
ADC buys
7
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$ADC▼ Sell$15,001 - $50,0002026-01-15
Lisa McClain🏢 House$ADC▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$ADC▲ Buy$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$ADC▼ Sell$1,001 - $15,0002025-06-17
Lisa McClain🏢 House$ADC▼ Sell$1,001 - $15,0002025-06-17
Lisa McClain🏢 House$ADC▲ Buy$1,001 - $15,0002025-06-11
Lisa McClain🏢 House$ADC▲ Buy$1,001 - $15,0002025-06-11
Josh Gottheimer🏢 House$ADC▼ Sell$1,001 - $15,0002025-04-09
Josh Gottheimer🏢 House$ADC▲ Buy$1,001 - $15,0002024-04-15
Josh Gottheimer🏢 House$ADC▼ Sell$1,001 - $15,0002024-03-14
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHKMPFADC
Forward yield4.85%4.11%
Annual dividend / share$0.84$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR85.6%40.4%
Portfolio after 10y$302.56M$176.9K
Annual income after 10y$279,218,818.50$79,647.25
Total dividends collected$300.79M$154.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: HKMPF vs ADC ($10,000, DRIP)

YearHKMPF PortfolioHKMPF Income/yrADC PortfolioADC Income/yrGap
1← crossover$11,601$900.60$10,987$577.21+$614.00HKMPF
2$14,225$1,812.21$12,293$855.34+$1.9KHKMPF
3$19,075$3,854.51$14,088$1,290.70+$5.0KHKMPF
4$29,376$8,965.67$16,660$1,994.91+$12.7KHKMPF
5$55,382$23,949.87$20,525$3,181.85+$34.9KHKMPF
6$137,579$78,320.34$26,654$5,286.90+$110.9KHKMPF
7$484,693$337,482.73$37,006$9,259.47+$447.7KHKMPF
8$2,580,955$2,062,333.89$55,862$17,338.74+$2.53MHKMPF
9$21,810,404$19,048,782.00$93,452$35,300.32+$21.72MHKMPF
10$302,555,951$279,218,818.50$176,931$79,647.25+$302.38MHKMPF

HKMPF vs ADC: Complete Analysis 2026

HKMPFStock

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

Full HKMPF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this HKMPF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HKMPF vs SCHDHKMPF vs JEPIHKMPF vs OHKMPF vs KOHKMPF vs MAINHKMPF vs NNNHKMPF vs EPRTHKMPF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.